REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,492,130 | +115.2% | 34,250 | +91.9% | 0.14% | +121.0% |
| Q1 2023 | $1,622,922 | -70.0% | 17,850 | -53.3% | 0.06% | -64.8% |
| Q2 2021 | $5,409,000 | +42.0% | 38,219 | 0.0% | 0.18% | +34.4% |
| Q1 2021 | $3,810,000 | -19.4% | 38,219 | 0.0% | 0.13% | -21.1% |
| Q4 2020 | $4,725,000 | -36.6% | 38,219 | -50.0% | 0.17% | -40.5% |
| Q3 2020 | $7,447,000 | -6.2% | 76,440 | +50.2% | 0.28% | -7.6% |
| Q2 2020 | $7,943,000 | +56.6% | 50,907 | +44.9% | 0.30% | +31.9% |
| Q1 2020 | $5,071,000 | -6.1% | 35,129 | +33.0% | 0.23% | +12.3% |
| Q4 2019 | $5,399,000 | – | 26,412 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |